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Abstract
Whilst the majority of inherited diseases have been found to be caused by single base substitutions, small insertions or
deletions (,1Kb), a significant proportion of genetic variability is due to copy number variation (CNV). The possible role of
CNV in monogenic and complex diseases has recently attracted considerable interest. However, until the development of
whole genome, oligonucleotide micro-arrays, designed specifically to detect the presence of copy number variation, it was
not easy to screen an individual for the presence of unknown deletions or duplications with sizes below the level of
sensitivity of optical microscopy (3–5 Mb). Now that currently available oligonucleotide micro-arrays have in excess of a
million probes, the problem of copy number analysis has moved from one of data production to that of data analysis. We
have developed CNViewer, to identify copy number variation that co-segregates with a disease phenotype in small nuclear
families, from genome-wide oligonucleotide micro-array data. This freely available program should constitute a useful
addition to the diagnostic armamentarium of clinical geneticists.
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Introduction
With the development of high throughput technologies,
genomics is rapidly moving into the clinical arena [1]. However,
clinical genomics poses significant challenges to physicians, who
need to be computer-literate if, as aptly expressed by Ware et al
[2], they wish to ‘‘surf the wave of genomic opportunity’’.
Traditionally, bioinformaticians have used software that makes
extensive use of command lines and LINUX operational systems.
Clinicians, in contrast, need user-friendly graphical software that is
preferably Windows-based and free. Consequently, we have tried
to address these concerns with the development of CNViewer, a
simple computer program for the visualization and analysis of
human genomic copy number variations (CNVs).
Recently, structural genomic rearrangements have been found
to be a major source of phenotypic variation [3,4]. They may
modify a gene’s activity and expression by changing its copy
number, altering its chromatin structure or by directly disrupting
the structure of the transcriptional unit. Consequently, they may
be a significant cause of genetic disease.
Although many chromosomal aberrations can be readily
identified through karyotypic studies, conventional cytogenetic
analysis cannot reliably detect rearrangements of genomic
segments smaller than 3–5 million base pairs (Mb) [5]. For
chromosomal rearrangements smaller than that, a number of
techniques including fluorescent in situ hybridization [6], multi-
plex ligation-dependent probe amplification [7], array-compara-
tive genomic hybridization (aCGH) [8] and microarray oligonu-
cleotide hybridisation [9] have been developed. The first two
depend on previous knowledge of the region to be scrutinized,
which is only possible when a specific clinical suspicion exists. On
the other hand, chromosomal micro-rearrangements vary in size
and are often associated with non-specific phenotypes. Thus, there
is a need for procedures that can screen the whole genome for
subtle structural alterations and the only ones that meet this
requirement are aCGH and oligonucleotide microarray hybrid-
isation.
With the development of microarrays containing CNV probes,
such as Affymetrix’s SNP 6.0 genotyping microarray, it is possible
to simultaneously genotype approximately 0.9 million SNPs and
screen for copy number variation with approximately 1.9 million
probes. Consequently, with the dual ability to genotype both SNPs
and CNVs, oligonucleotide microarray analysis has been used
extensively in genome-wide association studies (GWAS)
[10,11,12].
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To assist with the analysis of SNP and CNV microarray data, a
number of algorithms have been implemented in various software
applications [13,14,15]. Although, the error rate of microarray-
derived CNV detection is believed to be greater than that observed
with aCGH data [16,17], the technique is becoming increasingly
popular. The Canary (copy number genotyping), Birdseed (SNP
genotyping) and Birdseye (CNV discovery) suite of algorithms
implemented in the Affymetrix Genotyping Console [18,19]
perform genotyping and CNV detection in a multi-step manner.
Initially, the CNV probe intensities are compared against a map
of common known, copy number polymorphisms, allowing these
CNVs to be typed whilst also enabling the CNV probe intensities
to be grouped into clusters of inferred copy number. These clusters
are then employed to aid in the genotyping of SNPs whose allelic
copy number is expected to be 2 (homozygous for the probe-
specific allele), 1 (heterozygotes) or 0 (homozygous for the
alternative allele). Finally, a hidden Markov model, which uses
the probe intensity and copy number data gathered while
genotyping the SNPs and the common CNVs identifies regions
of either rare or de novo CNV [18,19]. Using such algorithms, it has
been possible to identify 56% of common CNVs that contain 2
probes and up to 94% of common CNVs that span 20 probes.
With a typical marker density of one probe per 1,600 bp, this
corresponds to CNVs of approximately 3.2 or 32 Kb in length,
respectively. When used to identify CNVs bio-informatically
inserted into biologically-derived data, the method detected
10%, 51% or 97.5% of the synthetic CNVs, which contained 2
(,3.2 Kb), 5 (,8 Kb) and 10 (,16 Kb) probes, respectively.
While the CNV detection algorithm implemented by the
Affymetrix Genotyping Console is able to detect the majority of
CNV within an individual, the visualisation and identification of
important CNVs may be quite difficult when using this or similar
software applications. Consequently, we have developed
CNViewer, a simple, free to use, user-friendly, Windows-based
software tool for use by clinicians, which allows the rapid
visualisation and detection of CNVs that may be linked to a
disease phenotype. Also, when used with data from multiple
members of a small pedigree, it can identify CNVs segregating
with a disease phenotype.
To demonstrate the program’s usefulness, we used CNViewer to
identify a deletion distal to PAX6 that co-segregates with
individuals affected by aniridia in one family. We also visualised
copy number data derived from two patients who presented with
severe developmental problems caused by large scale de novo
chromosomal re-arrangements. For comparison, these patients
had previously undergone aCGH analysis, which is currently the
method of choice for CNV detection in many clinical settings.
Finally, we also demonstrate the detection of a 160 Kb deletion
containing the DPY19L2 gene in a patient who presented with
suspected globozoospermia.
Results
Data visualisation and analysis
Copy number and LOH information derived from the
Affymetrix SNP 6.0 microarray contains both processed informa-
tion (CN state; copy number, and LOH), raw data (Log2Ratio;
copy number data and allele difference; loss of heterozygosity) and
partially processed data (Smooth signal; copy number). CNViewer
displays each of these data sets as a graph, containing information
for a single chromosome, with the Y-axis indicating the probe’s
value and the X-axis identifying the probe’s physical (in base pairs)
position on the chromosome. If the genomic localisation of the
genes and/or the cytogenetic bands on each chromosome are also
Figure 1. Detection of CNV using CNViewer. The ‘Smooth signal’ data for the tip of the long arm of chromosome 7 of Patient One has an
extended run of values tending around 1, representing the presence of a 6.5 Mb deletion (Figure 1A). The position of genes in the interval is shown
by the black rectangles below the main graph. The coloured blocks represent the location of the exons on the forward (green) and reverse (orange)
strands. The ‘Smooth signal’ data, from a 70 Mb region of chromosome 11, for each individual in Pedigree One is overlaid on the upper (affected
individuals) and lower graphs (unaffected siblings) in Figure 1B. The red box highlights regions where the CNVs are present in both affected and
unaffected individuals, while the blue boxes identify CNVs that are present in the affected but not unaffected individuals. When the ‘CN state’ data for
chromosome 11 is viewed with the ‘Show linked’ option selected, a single region starting at 31.7 Mb is highlighted (red bar, Figure 1C). When this
region is expanded it can be seen that all the affected individuals contain a deletion, which is absent from the unaffected individuals (Figure 1D). This
region contains 5 genes which are: 1 DCDC1; 2, DNAJC24; 3, IMMP1L; 4, ELP4; and 5, PAX6.
doi:10.1371/journal.pone.0043466.g001
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loaded and included in the analysis, such information is shown
below the data graphs. While LOH data points in the imported
data originate solely from the SNP genotype probes, the copy
number data is derived from both the copy number probes and the
SNP genotype probes. Consequently it is possible to view the copy
number data derived solely from the copy number probes, the
SNP genotype probes, or both probe sets.
If the analysis involves input from multiple individual subjects, it
is possible to highlight the data for each individual one at a time,
by selecting the appropriate file name from the list contained in
the ‘Overlay options’ panel. However, when viewing either the
CN state or LOH data for multiple individuals, it may be more
informative to select the ‘Show linked’ option. This option
highlights the probes that have a common value in the affected
patients but are not present in unaffected control patients.
Sub-microscopic structural variants are commonly found in
individuals with no known genetic disease. However, these
variants rarely exceed 100 Kb in length [3,4]. Consequently,
when large deletions/duplications (.1 Mb) are detected, it is not
necessary to compare the patient’s data with data derived from
control individuals, since a large deletion or duplication containing
multiple genes is unlikely to be benign. Therefore CNViewer
allows such data from a single patient to be viewed.
For example, Figure 1A shows the ‘Smooth signal’ values across
a ,6.5 Mb deletion affecting approximately 18 genes on
chromosome 7 of Patient One. However, as the size of the
structural variant decreases, it becomes increasingly difficult to
distinguish a pathological change from a non-pathological variant.
Therefore, CNViewer can also display patient data with reference
to data from unaffected individuals. This allows the selection of
variants that are present in all the affected individuals, but are
absent from unaffected control individuals. Thus, Figure 1B
highlights the ‘Smooth signal’ data points for the affected and
unaffected individuals in Pedigree One (upper and lower graphs,
respectively) spanning the first 70 Mb of chromosome 11. It can be
seen, that at a number of locations the data points diverge from the
expected copy number value of 2. The structural features that are
present in both affected and unaffected individuals, such as those
highlighted by the red box in Figure 1B, can be discounted as
being pathogenic, while those not present in the unaffected
individuals cannot be discounted (highlighted by the blue boxes in
Figure 1B). However, if the ‘CN state’ data for chromosome 11 is
viewed with the ‘Show linked’ option selected, only a single region
starting at 31.7 Mb is highlighted (red bar in Figure 1C). When
this region is expanded, it can be seen to contain a deletion that is
present in all the affected individuals, but absent from all the
unaffected individuals (Figure 1D). To allow further analysis of a
selected region it is possible to export the underlying data as a tab-
delimited text file, which can easily be viewed in a spread sheet
application such as Excel. A full description of the use of
CNViewer is given in the user guide at http://dna.leeds.ac.uk/
cnviewer/.
Pedigree One. When the Affymetrix SNP 6.0 copy number
data for the five affected and three unaffected members of
Pedigree One were analysed by CNViewer, only a single
0.57 Mb region of copy number variation was found to segregate
with the disease phenotype (Figure 1B to 1D). Starting at 31.7 Mb
of chromosome 11, this region was distal to PAX6 and while it did
not affect the transcribed regions of the PAX6 gene, it did contain
the D11S2001 microsatellite, the DCDC1, DNAJC24 and IMMP1L
genes, and the 59- coding sequences of the ELP4 gene. Deletions
distal to PAX6 have previously been shown to cause aniridia
[20,21,22] and are thought to inhibit the expression of the
associated PAX6 allele due to changes in the local chromatin
structure.
Figure 2. Identification of CNVs in patients 1, 2 and 3. Figures 2A to 2C show comparison of data from Patients One and Two, compared to
data from 8 individuals unrelated to the patients. Figures 2A and 2B display ‘Smooth signal’ data for chromosomes 7 and 21, respectively, for Patient
One and identify the location of a 7 Mb (152.1 to 159.0 Mb) deletion and a 10.2 Mb (36.8 to 47.0 MB) duplication. Figure 2C displays the ‘Smooth
signal’ data for chromosome 15 of Patient Two and shows an 18.5 Mb (81.8 to 100.3 Mb) duplication. Figure 2D displays the ‘CN state’ data, from
Patient Three, for an interval on chromosome 12 starting at 63.68 Mb and ending at 64.37 Mb. This clearly shows the presence of a 160 Kb
homozygous deletion, which encompasses the DPY10L2 gene locus (labelled 1), while not affecting the nearby TMEM5 and SRGAP1 (labelled 2 and 3,
respectively) genes.
doi:10.1371/journal.pone.0043466.g002
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Figure 3. Visualisation of chromosomes containing a large deletion, duplication or autozygous segments. Figures 3A, 3D, 3G, 3J and
3M contain a deleted region on the p arm of chromosome 7 in Patient One. Similarly, Figures 3B, 3E, 3H, 3K and 3N display the data for a duplication
on the p arm of chromosome 21 in Patient One. While Figures 3C, 3F, 3I, 3L and 3O show the presence of autozygous regions on chromosome 1 of
a consanguineous individual. Regions of copy number variation can be seen as a series of Log2 values that do not tend to zero (Figures 3A, 3B and
3C). These values are then used to create the Smooth signal data (Figures 3D, 3E and 3F). Finally, the CN state for each probe is determined and
shown as an integer value between 0 and 4 (Figures 3G, 3H and 3I). The genotype of each SNP probe is shown in the Allele difference dataset, which
typically contains three clusters of values representing the ‘AA’, ‘AB’ and ‘BB’ genotypes. Deletions can be seen where data points form just two
distinct clusters representing the A- and B- haploid genotypes (Figure 3J), while duplications are seen as four clusters of data points representing the
AAA, AAB, ABB and BBB triploid genotypes (Figure 3K). Autozygous regions can be determined by the absence of the central heterozygous cluster
(Figure 3L). LOH data points have a value of ‘Y’es or ‘N’o, with duplicated or deleted regions scoring N while autozygous regions or typically scored as
Y.
doi:10.1371/journal.pone.0043466.g003
Table 1. Comparison of the regions of CNV in Patients One and Two, identified by oligonucleotide aCGH and regions identified by
data derived from Affymetrix SNP 6.0 micro-array data.
Patient Chromosome Oligonucleotide aCGH Affymetrix and CNViewer
Type Interval (Mb) Size (Mb) Type Interval (Mb) Size (Mb)
One 7 Del 152.2 to158.8 6.6 Del 152.5 to 159.1 6.6
One 21 Dup 36.8 to 46.9 10.1 Dup 37.9 to 48.1 10.2
Two 15 Dup 83.7 to 102.5 18.8 Dup 84.0 to 102.5 18.5
doi:10.1371/journal.pone.0043466.t001
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Data selection guidelines when using CNViewer
Dominant Inheritance. CNViewer is able to identify regions
of copy number variation that segregate with a disease phenotype.
Analysis of the inheritance pattern of aniridia in Pedigree One
strongly suggested that the disease-causing mutation acted in a
dominant manner and had complete penetrance. Consequently, it
was possible to include unaffected siblings in the analysis. Since the
exclusion power of an affected patient is the same as an unaffected
sibling, in this case adding unaffected siblings significantly
increased the exclusion power of the family. However, if the
disease does not show complete penetrance, unaffected relatives
should not be included for analysis, since they could lead to the
exclusion of the disease locus.
Recessive Inheritance. Unlike dominantly-inherited diseas-
es, the exclusion power of affected and unaffected individuals is
not the same in recessively-inherited diseases. An affected
individual must inherit a disease allele from both parents, whereas
an unaffected child can inherit either no disease alleles or just one
from either the mother or father. Consequently, there is a 1 in 4
chance that two alleles co-segregate with the disease phenotype,
resulting in an individual affected by a recessive disease deing
more informative than an individual affected by a dominant
disease. Conversely, unaffected siblings of patients affected by a
recessive disease are less informative than siblings of patients
affected by a dominantly-inherited disease. Therefore, while the
inclusion of unaffected siblings may help to reduce the number
and size of candidate disease loci, in recessively-inherited
conditions it is more important to include data from affected
patients than their unaffected siblings. For a fuller description for
the exclusion power of CNViewer when analysing recessive and
dominant pedigrees is given in the supplementary document
Text S1.
Patient One. Analysis of the copy number data for Patient
One highlighted the two large structural variations previously
identified by oligonucleotide aCGH. These variants consisted of
the deletion of the telomeric region of the short arm of
chromosome 7 (152.1 to 159.0 Mb, Figure 2A) and the
duplication of the telomeric region of the long arm of chromosome
21 (36.8 to 47.0 Mb, Figure 2B).
Patient Two. Analysis of the copy number data for Patient
Two identified a single duplication of the telomeric region of the
long arm of chromosome 15 (81.8 to 100.3 Mb, Figure 2C),
consistent with findings for oligonucleotide aCGH analysis.
Patient Three. Since the patient was consanguineous, the
autozygosity status of the known disease loci was ascertained. Only
the DPY19L2 locus was found to lie in an autozygous region,
strongly implicating this locus as pathogenic. Analysis of copy
number status across the possible disease loci identified a 160 Kb
homozygous deletion that spanned the DPY19L2 gene (chromo-
some 12, 63,952,693 bp to 64,062,354 bp) (Figure 2D). Together,
the autozygosity mapping and CNV data strongly suggest that this
is the causative mutation in this individual.
Identification of regions of autozygosity, hemizygosity
and uniparental disomy
Figure 3 contains 3 series of images that display the graphs
generated by CNViewer for deleted (Figures 3A, 3D, 3G, 3J and
3M), duplicated (Figure 3B, 3E, 3H, 3K, and 3N) and autozygous
(Figure 3C, 3F, 3I, 3L and 3O) regions for each of the five different
data value types. While regions containing a deletion (Figure 3G)
are identified as having a copy number of 1 (CN state), they are
not highlighted as regions of loss of heterozygosity (LOH)
(Figure 3M). However, autozygous regions in consanguineous
individuals are identified as having LOH (Figure 3O). Conse-
quently, users who are interested in identifying regions of
hemizygosity caused by allele loss should identify regions with
CN state values of 1 and not use the LOH data set. However, the
LOH data does identify regions of autozygosity and uniparental
disomy, which are not detected by the CN state data points.
Identification of copy number variants not associated
with known disease loci
To demonstrate the ability of CNViewer to aid the detection of
copy number variation not associated with a known disease locus,
5 sets of randomly selected data files where created such that each
set contained two files assigned as ‘Affected’ and two files assigned
as ‘Unaffected’. Each set was then manually screened for naturally
occurring copy number variants (not using CNViewer) that were
present in both the ‘Affected’ files but not in either of the
‘Unaffected’ files of at least one set. Each copy number variant
spanned at least 6 consecutive probes and was not part of a larger
copy number variant that did not co-segregate. These copy
number variants were then used to create a group of 26
segregating copy number variants with lengths between 236 to
140,290 bp, and containing between 6 to 70 probes (Table S1).
Two CNViewer users where then asked to identify all the copy
number variants in the sets using only the CN state data values.
Both users identified very similar sets of copy number variants
each containing all the previously identified copy number variants.
Regions identified by one user but not the other were subsequently
found to be due to different selection criteria, with one user
disregarding small regions of copy number variation if they were
linked to larger CNV regions that did not segregate.
Discussion
Copy number variation has generally been examined in the
context of genome-wide association studies [23] and cancer
genomics [24,25], resulting in the development of software
applications that are not suited to identifying regions of CNV
that segregate with a disease phenotype in a pedigree or nuclear
family. Consequently, we developed CNViewer to aid the
visualisation of CNV data derived from Affymetrix’s SNP 6.0
genotyping micro-array.
When used to screen CNV data from 5 affected and 3
unaffected members of a pedigree affected by aniridia, CNViewer
identified a single region of CNV that co-segregated within the
affected individuals. This deletion was found to be distal to PAX6,
a region where similar deletions have previously been found in
patients affected by aniridia [20,21,22].
When CNViewer was used to visualise CNV data from
Patients One and Two with severe developmental problems,
it was able to quickly identify the same regions as those found by
oligonucleotide aCGH. When CNV data from Patient Three
was observed using CNViewer across the known globozoospermia
disease loci, only the DPY19L2 locus was found to be affected by a
homozygous deletion. Since the other known disease loci appeared
normal, this strongly suggests that this deletion is the cause of
globozoospermia in this patient.
CNViewer can aid the rapid detection of large (.1Mb) regions
of copy number variation and smaller regions linked to a known
disease-causing locus. However, while it is also able to detect
regions of copy number variation not linked to a known disease
locus, when doing so it is important to decide on the minimum
number of probes that will delimit a copy number variant and how
regions connected to larger, none-segregating regions are treated.
As with aCGH, CNViewer analysis identifies regions of copy
number variation, but does not identify the mechanism by which
Detection of CNV Features Linked to Disease
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the variants cause a phenotype. For example, a duplication may
give rise to a phenotype by affecting the expression of a gene
present in the duplication or at the site of the duplication’s
insertion. Consequently, if a region of increased copy number is
found to segregate with a disease phenotype, it will still be
necessary to identify the exact mechanism by which the
duplication causes or influences the phenotype.
While aCGH is the method of choice for copy number analysis
for many clinical geneticists, the fact that current SNP genotyping
microarrays offer the ability to both identify CNVs and genotype
patients at no extra expense means that this technique is likely to
become more important by identifying CNV linked to disease
phenotypes. This can be seen in Patient Three, where a
combination of both autozygosity mapping and identification of
regions of copy number variation strongly implicated the deletion
of a known gene as the cause of the patient’s condition. While
other programs, such as CNAG [14] and Affymetrix’s Genotyping
Console can visualise copy number data, CNViewer was
developed to provide a more user-friendly system that can rapidly
and easily identify CNV associated with a disease phenotype.
CNViewer should become a useful addition to the toolbox of the
clinical geneticist.
Materials and Methods
Ethical standards
Informed written consent was obtained from all adult partic-
ipants and the parents or guardians of minors or children, and the
study was approved by the Leeds (East) Research Ethics
Committee (REC ref. no. 08/H1306/85).
Software development and requirements
CNViewer has been tested on Microsoft Windows XP SP3,
Vista SP1 and Windows 7, and requires the installation of the.
NET framework 2.0. The program, user guide and sample files are
freely available for download at http://dna.leeds.ac.uk/cnviewer/
and https://sourceforge.net/projects/cnviewer/.
Data requirements
CNViewer is designed to analyse data derived from the copy
number analysis of Affymetrix SNP 6.0 microarrays performed by
the Affymetrix Genotype Console software. Although it is possible
to export copy number, log2 ratio, smoothed signal, loss of
heterozygosity (LOH) and allele difference values from the
Genotyping Console, CNViewer does not require that all these
fields be included in the exported data set.
Patients
To demonstrate the ability of CNViewer to correctly identify
regions of copy number variation segregating with a disease
phenotype, we used the Affymetrix Genotyping Console to infer
the copy number and LOH values from Affymetrix SNP 6.0
microarray data (Aros Applied Biotechnology A/S, Denmark)
derived from the individuals described below.
Pedigree One (Figure S1) consists of two related nuclear
families affected by aniridia (MIM# 106210), congenital absence
of the iris associated with cataracts, corneal changes, and macular
and optic nerve hypoplasia. This condition is known to be caused
by dominantly-acting mutations in PAX6 [26]. When the PAX6
exonic sequences in the affected members of the pedigree were
sequenced, no mutations were found. However, microsatellite
analysis with the marker D11S2001, suggested that the affected
patients were heterozygous for a deletion close to, but beyond the
previously recognised 39-extremity of PAX6.
Patients One and Two were referred for investigation of
severe physical and mental developmental problems. These
patients had previously undergone diagnostic oligonucleotide
aCGH analysis using the Human Genome CGH Microarray
Kit 44B (Agilent Technologies, Wilmington, DE) as described by
Fan et al. [27], performed by an accredited service provider
(Cytogenetic and Molecular Diagnostic Laboratory, Miller School
of Medicine, University of Miami). This analysis had identified at
least one large de novo chromosomal rearrangement in each patient
(Table 1).
Patient Three was a consanguineous individual referred for
investigation having received a preliminary diagnosis of globo-
zoospermia (MIM# 613958). This condition had previously been
linked to disruption of the human SPATA16, and mouse Gopc or
Pick1 genes [28,29,30] or the deletion of the DPY19L2 locus
mediated through the presence of low copy number repeats
flanking that gene [31].
Supporting Information
Figure S1 Figure S1A shows the structure of Pedigree One,
which consists of two related nuclear families affected by aniridia.
The asterisk by the patients’ ID numbers identifies individuals for
whom CNV data was collected. Microsatellite sizes for the marker
D11S2001 are shown below each pedigree symbol. Figure S1B
shows the structure of a hypothetical consanguineous pedigree in
which 3 out 6 siblings are affected by a recessive condition.
(TIF)
Table S1 From a collection of 12 copy number data
files, 5 sets of files were created such that each set had
two files assigned as affected and two files assigned as
unaffected. These sets where then manually screened (not using
CNViewer) for naturally occurring copy number variant, in the
autosomal chromosomes, which were present in both affected files,
but not the unaffected files of a set. A set of 30 naturally-occurring
copy number variants were then used to test the ability of three
users to identify the previously identified copy number variants in
each set.
(DOC)
Text S1 Exclusion power of CNViewer when analysing
dominant and recessive pedigrees.
(DOC)
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